2. Metabolic Enzyme/Protease Apoptosis
  3. Endogenous Metabolite Apoptosis
  4. (-)-Epigallocatechin Gallate

(-)-Epigallocatechin Gallate  (Synonyms: EGCG; Epigallocatechol Gallate)

Cat. No.: HY-13653 Purity: 99.87%
COA Handling Instructions

(-)-Epigallocatechin Gallate (EGCG) is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. (-)-Epigallocatechin Gallate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma.

For research use only. We do not sell to patients.

(-)-Epigallocatechin Gallate Chemical Structure

(-)-Epigallocatechin Gallate Chemical Structure

CAS No. : 989-51-5

Size Price Stock Quantity
Free Sample (0.1 - 0.5 mg)   Apply Now  
Solution
10 mM * 1 mL in DMSO USD 61 In-stock
Solid + Solvent
10 mM * 1 mL
ready for reconstitution
 USD 61 In-stock
Solid
50 mg USD 55 In-stock
100 mg USD 72 In-stock
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 28 publication(s) in Google Scholar

Other Forms of (-)-Epigallocatechin Gallate:

(-)-Epigallocatechin Gallate Related Antibodies

Top Publications Citing Use of Products

    (-)-Epigallocatechin Gallate purchased from MCE. Usage Cited in: Oncol Lett. 2017 Nov;14(5):6314-6320.  [Abstract]

    Effects of EGCG on the levels of SHP 1 and p p38α protein expres¬sion in NB4 cells.

    • Biological Activity

    • Purity & Documentation

    • References

    • Customer Review

    Description

    (-)-Epigallocatechin Gallate (EGCG) is a major polyphenol in green tea, which can inhibit cell proliferation and induce cell apoptosis. (-)-Epigallocatechin Gallate inhibits glutamate dehydrogenase 1/2 (GDH1/2, GLUD1/2) activity. (-)-Epigallocatechin Gallate has a potent anticancer, antioxidant and anti-inflammatory properties against various types of cancers such as colorectal cancer, myeloid leukemia, thyroid carcinoma[1][2][3][4].

    IC50 & Target[1]

    EGFR

     

    HER2

     

    HER3

     

    In Vitro

    (-)-Epigallocatechin Gallate (EGCG, 10-60 μM) inhibits the growth of FB-2 and WRO cells in a dose-dependent manner[1].
    (-)-Epigallocatechin Gallate (10-60 μM, 0-24 h) reduces cyclin D1 and phosphorylation of AKT and ERK1/2, and increases p21 and p53 expression[1].
    (-)-Epigallocatechin Gallate (10-60 μM, 12 h) reduces cell motility and migration[1].
    (-)-Epigallocatechin Gallate (0-20 μM, 0-20 min approximately) inhibits GLUD1/2 and IDH1 activity in a concentration and time-dependent way (biochemical assays)[2].
    (-)-Epigallocatechin Gallate (0-35 μg/mL, 24-72 h) inhibits the proliferation of colorectal cancer cells (LoVo, SW480, HT-29, HCT-8 cells), increases cell apoptosis and blocks cells at the G0/G1 phase[3].
    (-)-Epigallocatechin Gallate (30 μM, 3-24 h) suppresses the expression of COX-2 and mPGES-1 mRNAs, prostaglandin E2 production in LPS-induced osteoblasts[4].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    (-)-Epigallocatechin Gallate Related Antibodies

    Cell Proliferation Assay[1]

    Cell Line: FB-2 and WRO cells (serum-starved for 48h)
    Concentration: 10, 40, 60 μM.
    Incubation Time: 4 days
    Result: Inhibited basal cell proliferation (40% in FB-2 and 35% in WRO) at 10 μM, inhibited cell number (by 68% to 73%) at 40 and 60 μM).

    Western Blot Analysis[1]

    Cell Line: FB-2 cells
    Concentration: 10, 40, 60 μM.
    Incubation Time: 24 h
    Result: Reduced cyclin D1 level, phosphorylation of AKT and ERK1/2.
    Induced the expression of p21 and p53, and E-cadherin, N-cadherin, Vimentin and α5-integrin.

    Cell Migration Assay [1]

    Cell Line: FB-2 and WRO cells (serum-starved for 48h)
    Concentration: 10, 40, 60 μM.
    Incubation Time: 12 h
    Result: Reduced migration activity in FB-2 and WRO cells.

    RT-PCR[4]

    Cell Line: Mouse primary osteoblasts (1 ng/ml LPS-treated)
    Concentration: 30 μM
    Incubation Time: 3, 6, 12, 24 h
    Result: Suppressed the LPS-induced expression of COX-2 and mPGES-1 mRNAs, prostaglandin E2 production.
    In Vivo

    (-)-Epigallocatechin Gallate (Intragastrical administration, 5-20 mg/kg, once daily for 14 days, orthotopic transplant model) decreases tumors growth[3].
    (-)-Epigallocatechin Gallate (Injected into the mouse lower gingiva, a single dose of 0.5 mg/mouse, experimental periodontitis model) decreases inhibits the LPS-induced loss of bone mineral density (BMD)[3].

    MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    Animal Model: Orthotopic transplant BALB/c nude mice model[3]
    Dosage: 5, 10, and 20 mg/kg, once daily for 14 days.
    Administration: Intragastrical administration.
    Result: Inhibited tumors growth with no liver or lung metastases.
    Animal Model: Model of experimental periodontitis, LPS (25 μg/mouse)[4]
    Dosage: 0.5 mg/mouse, a single dose.
    Administration: Injected into the mouse lower gingiva
    Result: Inhibited the LPS-induced loss of bone mineral density (BMD) in mice.
    Clinical Trial
    Molecular Weight

    458.37

    Appearance

    Solid

    Formula

    C22H18O11
    CAS No.
    SMILES

    O=C(O[C@H]1[C@@H](C2=CC(O)=C(O)C(O)=C2)OC3=CC(O)=CC(O)=C3C1)C4=CC(O)=C(O)C(O)=C4
    Structure Classification
    Initial Source
    Shipping

    Room temperature in continental US; may vary elsewhere.
    Storage
    Powder -20°C 3 years
    4°C 2 years
    In solvent -80°C 6 months
    -20°C 1 month
    Solvent & Solubility
    In Vitro: 

    DMSO : ≥ 30 mg/mL (65.45 mM)

    H2O : 20 mg/mL (43.63 mM; Need ultrasonic)

    *"≥" means soluble, but saturation unknown.

    Preparing
    Stock Solutions
    Concentration Solvent Mass 1 mg 5 mg 10 mg
    1 mM 2.1816 mL 10.9082 mL 21.8164 mL
    5 mM 0.4363 mL 2.1816 mL 4.3633 mL
    10 mM 0.2182 mL 1.0908 mL 2.1816 mL
    *Please refer to the solubility information to select the appropriate solvent.
    In Vivo:
    • 1.

      Add each solvent one by one:  PBS

      Solubility: 9.09 mg/mL (19.83 mM); Clear solution; Need ultrasonic and warming and heat to 60°C

    • 2.

      Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% saline

      Solubility: ≥ 2.08 mg/mL (4.54 mM); Clear solution

    • 3.

      Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in saline)

      Solubility: ≥ 2.08 mg/mL (4.54 mM); Clear solution

    • 4.

      Add each solvent one by one:  10% DMSO    90% corn oil

      Solubility: ≥ 2.08 mg/mL (4.54 mM); Clear solution

    *All of the co-solvents are available by MCE.
    Purity & Documentation

    Purity: 99.87%

    COA (256 KB) LCMS (266 KB)

    Handling Instructions (2659 KB)
    References
    • No file chosen (Maximum size is: 1024 Kb)
    • If you have published this work, please enter the PubMed ID.
    • Your name will appear on the site.

    (-)-Epigallocatechin Gallate Related Classifications

    Help & FAQs
    • Do most proteins show cross-species activity?

      Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

    • Molarity Calculator

    • Dilution Calculator

    The molarity calculator equation

    Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

    Mass   Concentration   Volume   Molecular Weight *
    = × ×

    The dilution calculator equation

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

    This equation is commonly abbreviated as: C1V1 = C2V2

    Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
    × = ×
    C1   V1   C2   V2

    Keywords:

    (-)-Epigallocatechin Gallate989-51-5EGCG Epigallocatechol GallateEndogenous MetaboliteApoptosisThyroid cancerFB-2 cellsLPS-induced bone resorptioncolorectal cancercell proliferation.Inhibitorinhibitorinhibit

    Your Recently Viewed Products:

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Salutation

    Applicant Name *

    		 

    Email Address *

    Phone Number *

    		 

    Organization Name *

    Department *

    		 

    Requested quantity *

    Country or Region *

    		      

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    (-)-Epigallocatechin Gallate
    Cat. No.:
    HY-13653
    Quantity:
    MCE Japan Authorized Agent:

    Customer Review

    Thank You for Your Feedback!

    Request for HNMR Report

    Please fill out this form to request the QC report. We will send it to your Email address shortly.

    Your information is safe with us. * Required Fields.

    Product Name

    		  

    Lot #

    Applicant Name *

    		 

    Email Address *

    Phone Number

    		 

    Department *

    Organization Name *

    		 

    Country or Region *

    Remarks

    Request for HNMR Report

    We have received your request and will respond to you as soon as possible.